株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

研究および体外診断用途(質量分析、クロマトグラフィ、マイクロアレイ、電気泳動、免疫測定ほか)対応プロテオミクスの世界市場

Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, & Other Technologies)

発行 Kalorama Information 商品コード 314227
出版日 ページ情報 英文 461 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
研究および体外診断用途(質量分析、クロマトグラフィ、マイクロアレイ、電気泳動、免疫測定ほか)対応プロテオミクスの世界市場 Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, & Other Technologies)
出版日: 2014年09月04日 ページ情報: 英文 461 Pages
概要

プロテオミクスはたんぱく質の研究であり、これにはたんぱく質の構造や機能、相互作用、発現するたんぱく質の特定、発現の時と場所についての研究が含まれます。プロテオミクスは研究市場に重点を置く広範な分野ですが、その一方で、治療学や診断学にも利用されています。

当レポートでは、研究および体外診断に利用されるプロテオミクスの世界市場に注目し、その技術・用途の概要を探るとともに、今後2018年までの期間を対象として市場の推移を予測するほか、事業の動向や発展への影響要因、課題、地域分析、競合環境、主要参入企業などに関する最新情報を集めています。

第1章 エグゼクティブサマリー

  • 概要
  • 調査の範囲と方法
  • 市場概況
  • プロテオミクス市場の将来見通し

第2章 イントロダクション

  • プロテオミクス
  • ヒトプロテオミクスプロジェクトとヒトプロテオーム機構
  • 視点

第3章 技術

  • 質量分析
  • 概要
  • 質量分析プラットフォームおよび関連製品を商業化する企業
  • 質量分析を独自のプロテオミクス技術に活用する企業
  • 臨床検査室での質量分析
  • クロマトグラフィ
  • 液体クロマトグラフィ(LC)と高性能液体クロマトグラフィ(HPLC)の概要
  • 他形式のクロマトグラフィ
  • マイクロアレイ
  • マイクロ流体工学
  • 電気泳動
  • ゲル電気泳動
  • キャピラリー電気泳動
  • 免疫測定(抗体によるタンパク質捕獲)
  • バイオインフォマティクス

第4章 プロテオミクスの応用分野

  • 研究およびバイオマーカー検出、創薬および薬剤開発
  • 体外診断

第5章 プロテオミクス企業への投資および資金提供契約

  • 他社との間における契約
  • プロテオミクス企業の買収
  • 主な他の契約法

第6章 業界連合体

  • Worldwide Protein Data Bank (wwPDB)
  • neXtProt
  • PeptideAtlas
  • Protein Identification Database (PRIDE)
  • ProteomeXchange
  • The Human Protein Atlas
  • UniProt Consortium and UniProtKB
  • The Biomarkers Consortium
  • Biomarkers Research Initiatives in Mass Spectometry (BRIMS)
  • Clinical Proteomic Tumor Analysis Consortium (CPTAC)
  • Critical Path Initiative and Predictive Safety Testing Consortium
  • Early Detection Research Network (EDRN)
  • National Biomarker Development Alliance (NBDA)
  • Geneva Bioinformatics (GeneBio) SA and Swiss Institute of Bioinformatics (SIB)

第7章 課題と動向

  • プロテオミクス市場の推進要因
  • 研究市場に狙いを定めたプロテオミクス企業が向き合う課題と障害
  • 体外診断市場で企業が向き合う課題と障害
  • 市場分析

第8章 プロテオミクスのツールやプラットフォームを販売または開発している企業

目次
Product Code: KLI5321482

This Kalorama Information report defines markets and identifies trends for proteomics applications, both in their research use and in IVD. Proteomics is the study of proteins, including the study of the structure and function of proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles of proteins, and interactions of proteins. Proteomics is a large field that has focused on research markets but has applications in therapeutics and diagnostics.

Proteomics Markets for Research and IVD Applications reflects Kalorama's market estimates, forecasts and competitive analysis of this important are. As part of its coverage, this report includes the following important data:

  • Proteomics Technologies, including: Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Bioinformatics, and Others, plus Discussion of Companies Commercializing Platforms Enabling Others to Use These Technologies
  • Applications of Proteomics, including: Research and Biomarker discovery, Drug Discovery and Development, and in Vitro Diagnostics (IVD)
  • Deals made by Proteomics Companies: Mergers, Partnerships, Investments
  • Consortia and Alliances in Proteomics
  • Proteomics Sales by Geographical Region, Worldwide, (North America, Europe, Asia, ROW)
  • Market Issues and Opportunities, Including Market Drivers for Immunoassays
  • Market Estimates for Mass Spectrometry in Proteomics and Forecast to 2018
  • Market Estimates for Chromatography in Proteomics and Forecast to 2018
  • Market Estimates for Microarrays in Proteomics and Forecast to 2018
  • Market Estimates for Electrophoresis in Proteomics and Forecast to 2018
  • Market Estimates for Immunoassays in Proteomics and Forecast to 2018
  • Market Estimates for IVD Applications of Proteomics
  • Market Estimates for Research Applications of Proteomics
  • Extensive Profiles of Companies
  • Product and Service Market Opportunity for Proteomics

The information presented in this report is derived from publicly available information sources such as company reports and announcements, government reports and databases, medical organization reports, medical associations, and other publications. The analysis is based on the author's industry knowledge combined with literature searches and discussions with industry professionals and experts in the areas of point-of-care tests, decentralized healthcare and healthcare economics.

Understanding the human proteome is a much larger and more challenging task than the Human Genome Project was. The proteome is much more complex as it can change based on factors that affect which genes are expressed. Also, after proteins are expressed, proteins may be modified. Proteomics will remain a very active area of research for several years, and the knowledge derived from this research is expected to produce advances in the diagnosis and treatment of diseases.r decades, many advances are being made in this field. Other major technology segments include chromatography, electrophoresis, microarrays, and other technologies.

Companies discussed in this report include those who with proteomics platforms and related products, commercializing technologies such as mass spectrometry or other proteomics technologies. In addition, this report discusses the proteomics research, services, and products developed and marketed by companies using these proteomics technologies and platforms. Many of the companies in this second group have developed their own proprietary proteomic technologies that utilize technologies such as mass spectrometry or other proteomic technologies.

Companies profiled in this report include:

  • Abbott Laboratories
  • AB SCIEX (A Danaher Corporation Company)
  • ActivX Biosciences, Inc. (Owned by Kyorin Pharmaceuticals)
  • Advion, Inc.
  • Affymetrix, Inc.
  • Agilent Technologies Inc.
  • Arbor Vita Corporation
  • ArcDia International Oy Ltd
  • Arrayit Corporation
  • Atonomics A/S
  • Avant Diagnostics, Inc.
  • Axela, Inc.
  • AXO Science
  • AYOXXA Biosystems GmbH
  • Banyan Biomarkers
  • Beckman Coulter, Inc.
  • (Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company (BD)
  • BG Medicine, Inc.
  • BioAnalyte Inc.
  • Biocartis SA
  • Biodesix, Inc.
  • Biognosys AG
  • bioMérieux SA
  • BioMosaics Inc.
  • Bioproximity, LLC
  • Bio-Rad Laboratories, Inc.
  • Biosensia Ltd.
  • BioSystems International
  • Bruker Corporation
  • Cambridge Protein Arrays Ltd.
  • Caprion, Inc.
  • caprotec bioanalytics GmbH
  • CardioGenics Holdings, Inc.
  • CD Diagnostics, Inc.
  • CDI Laboratories
  • Chromsystems Instruments & Chemicals GmbH
  • Clearbridge BioLoc Pte Ltd.
  • Courtagen Life Sciences, Inc.
  • CovalX AG
  • CRELUX GmbH
  • Crescendo Bioscience (Subsidiary of Myriad Genetics)
  • CyVek Inc.
  • Danaher Corporation
  • Dasit Group - Focusing on
  • DECODON GmbH
  • DiAssess Inc.
  • Digilab, Inc.
  • Dualsystems Biotech AG
  • EMD
  • Euroimmun AG
  • Evotec AG
  • Expedeon, Inc.
  • Fluidigm
  • Fujirebio Inc.
  • GE Healthcare Life Sciences
  • Genalyte, Inc.
  • GeneFluidics, Inc.
  • Geneva Bioinformatics (GeneBio) SA
  • GWC Technologies
  • Helena Laboratories
  • Hoefer, Inc. (Subsidiary of Harvard Bioscience, Inc.)
  • Hybrigenics SA
  • ImaBiotech SAS
  • Immunexpress Group
  • Immunovia AB
  • InDevR, Inc.
  • Insilicos LLC
  • Integrated Diagnostics, Inc.
  • Integromics S.L.
  • Intuitive Biosciences, Inc.
  • JOEL Ltd.
  • KineMed, Inc.
  • Kinexus
  • LEAP Technologies, Inc.
  • Life Technologies Corporation
  • LSI Medience Corporation
  • Luminex Corporation
  • MagArray Inc.
  • Matrix Science Limited
  • MBio Diagnostics, Inc.
  • Microlytic ApS
  • QuantiScientifics, LLC
  • Quidel Corporation
  • Rigaku Reagents, Inc.
  • Roche Diagnostics
  • Sebia, Inc.
  • Sera Prognostics, Inc.
  • Shimadzu Corporation
  • Siemens Healthcare Diagnostics
  • Sigma-Aldrich Corporation
  • Singulex, Inc.
  • SISCAPA Assay Technologies, Inc.
  • SomaLogic, Inc.
  • SpOtOn Clinical Diagnostics Limited
  • SQI Diagnostics Inc.
  • STAT-Diagnostica
  • Syngene (Division of Synoptics Ltd)
  • T2 Biosystems, Inc.
  • Tecan Group AG
  • The Binding Site Group Ltd.
  • Theranostics Health Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Venaxis, Inc. (Formerly Aspen BioPharma, Inc.)
  • Wako Diagnostics
  • Waters Corporation

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Overview
  • Scope and Methodology
  • Market Overview
  • Future Prospects for the Proteomics Market

CHAPTER TWO: INTRODUCTION

  • Proteomics
  • Human Proteomics Project and Human Proteome Organization
  • Point of View

CHAPTER THREE: TECHNOLOGIES

  • Mass Spectrometry
  • Overview
  • Companies Marketing Mass Spectrometry Platforms and Related Products
  • Companies Utilizing Mass Spectrometry in Proprietary Proteomics Technology
  • Mass Spectrometry in the Clinical Laboratory
  • Chromatography
  • Liquid Chromatography (LC) and High Performance Liquid Chromatography (HPLC) Overview
  • Other Types of Chromatography
  • Microarrays
  • Microfluidics
  • Electrophoresis
  • Gel Electrophoresis
  • Capillary Electrophoresis
  • Immunoassays (Protein Capture by Antibodies)
  • Bioinformatics

CHAPTER FOUR: PROTEOMICS APPLICATIONS

  • Research and Biomarker Discovery, Drug Discovery and Development
  • In Vitro Diagnostics

CHAPTER FIVE: INVESTMENTS AND FINANCING AGREEMENTS FOR PROTEOMICS COMPANIES

  • Agreements Between with Other Companies
  • Acquisitions of Proteomics Companies
  • Selected Other Agreements

CHAPTER SIX: CONSORTIA

  • Worldwide Protein Data Bank (wwPDB)
  • neXtProt
  • PeptideAtlas
  • Protein Identification Database (PRIDE)
  • ProteomeXchange
  • The Human Protein Atlas
  • UniProt Consortium and UniProtKB
  • The Biomarkers Consortium
  • Biomarkers Research Initiatives in Mass Spectometry (BRIMS)
  • Clinical Proteomic Tumor Analysis Consortium (CPTAC)
  • Critical Path Initiative and
  • Predictive Safety Testing Consortium
  • Early Detection Research Network (EDRN)
  • National Biomarker Development Alliance (NBDA)
  • Geneva Bioinformatics (GeneBio) SA and Swiss Institute of Bioinformatics (SIB)

CHAPTER SEVEN: ISSUES AND TRENDS

  • Proteomics Market Drivers
  • Issues and Hurdles Faced by Proteomics Companies Targeting Research Markets
  • Issues and Hurdles Faced by Companies in the in vitro Diagnostics Market
  • Future Prospects

CHAPTER EIGHT: MARKET ANALYSIS

  • Proteomics Product Market Segments by Type of Technology

CHAPTER NINE: COMPANIES MARKETING OR DEVELOPING PROTEOMICS TOOLS AND PLATFORMS

  • Abbott Laboratories
  • AB SCIEX (A Danaher Corporation Company)
  • ActivX Biosciences, Inc. (Owned by Kyorin Pharmaceuticals)
  • Advion, Inc.
  • Affymetrix, Inc.
  • Arbor Vita Corporation
  • ArcDia International Oy Ltd
  • Arrayit Corporation
  • Atonomics A/S
  • Avant Diagnostics, Inc.
  • Axela, Inc.
  • AXO Science
  • AYOXXA Biosystems GmbH
  • Banyan Biomarkers
  • Beckman Coulter, Inc.
  • (Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company (BD)
  • BG Medicine, Inc.
  • BioAnalyte Inc.
  • Biocartis SA
  • Biodesix, Inc.
  • Biognosys AG
  • bioMérieux SA
  • BioMosaics Inc.
  • Bioproximity, LLC
  • Bio-Rad Laboratories, Inc.
  • Biosensia Ltd.
  • BioSystems International
  • Bruker Corporation
  • Cambridge Protein Arrays Ltd.
  • Caprion, Inc.
  • caprotec bioanalytics GmbH
  • CardioGenics Holdings, Inc.
  • CD Diagnostics, Inc.
  • CDI Laboratories
  • Chromsystems Instruments & Chemicals GmbH
  • Clearbridge BioLoc Pte Ltd.
  • Courtagen Life Sciences, Inc.
  • CovalX AG
  • CRELUX GmbH
  • Crescendo Bioscience (Subsidiary of Myriad Genetics)
  • CyVek Inc.
  • Danaher Corporation
  • Dasit Group - Focusing on
  • DECODON GmbH
  • DiAssess Inc.
  • Digilab, Inc.
  • Dualsystems Biotech AG
  • EMD
  • Euroimmun AG
  • Evotec AG
  • Expedeon, Inc.
  • Fluidigm
  • Fujirebio Inc.
  • GE Healthcare Life Sciences
  • Genalyte, Inc.
  • GeneFluidics, Inc.
  • Geneva Bioinformatics (GeneBio) SA
  • GWC Technologies
  • Helena Laboratories
  • Hoefer, Inc. (Subsidiary of Harvard Bioscience, Inc.)
  • Hybrigenics SA
  • ImaBiotech SAS
  • Immunexpress Group
  • Immunovia AB
  • InDevR, Inc.
  • Insilicos LLC
  • Integrated Diagnostics, Inc.
  • Integromics S.L.
  • Intuitive Biosciences, Inc.
  • JOEL Ltd.
  • KineMed, Inc.
  • Kinexus
  • LEAP Technologies, Inc.
  • Life Technologies Corporation
  • LSI Medience Corporation
  • Luminex Corporation
  • MagArray Inc.
  • Matrix Science Limited
  • MBio Diagnostics, Inc.
  • Microlytic ApS
  • QuantiScientifics, LLC
  • Quidel Corporation
  • Rigaku Reagents, Inc.
  • Roche Diagnostics
  • Sebia, Inc.
  • Sera Prognostics, Inc.
  • Shimadzu Corporation
  • Siemens Healthcare Diagnostics
  • Sigma-Aldrich Corporation
  • Singulex, Inc.
  • SISCAPA Assay Technologies, Inc.
  • SomaLogic, Inc.
  • SpOtOn Clinical Diagnostics Limited
  • SQI Diagnostics Inc.
  • STAT-Diagnostica
  • Syngene (Division of Synoptics Ltd)
  • T2 Biosystems, Inc.
  • Tecan Group AG
  • The Binding Site Group Ltd.
  • Theranostics Health Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Venaxis, Inc. (Formerly Aspen BioPharma, Inc.)
  • Wako Diagnostics
  • Waters Corporation
Back to Top